172 related articles for article (PubMed ID: 15855495)
1. Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi.
Booker BM; Smith PF; Forrest A; Bullock J; Kelchlin P; Bhavnani SM; Jones RN; Ambrose PG
Antimicrob Agents Chemother; 2005 May; 49(5):1775-81. PubMed ID: 15855495
[TBL] [Abstract][Full Text] [Related]
2. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
Crump JA; Barrett TJ; Nelson JT; Angulo FJ
Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
4. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Ray P; Sharma J; Marak RS; Garg RK
Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
[TBL] [Abstract][Full Text] [Related]
5. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
Crump JA; Kretsinger K; Gay K; Hoekstra RM; Vugia DJ; Hurd S; Segler SD; Megginson M; Luedeman LJ; Shiferaw B; Hanna SS; Joyce KW; Mintz ED; Angulo FJ;
Antimicrob Agents Chemother; 2008 Apr; 52(4):1278-84. PubMed ID: 18212096
[TBL] [Abstract][Full Text] [Related]
6. Revisit of fluoroquinolone and azithromycin susceptibility breakpoints for Salmonella enterica serovar Typhi.
Das S; Ray U; Dutta S
J Med Microbiol; 2016 Jul; 65(7):632-640. PubMed ID: 27221661
[TBL] [Abstract][Full Text] [Related]
7. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
[TBL] [Abstract][Full Text] [Related]
8. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
9. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
10. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy.
Parry CM; Vinh H; Chinh NT; Wain J; Campbell JI; Hien TT; Farrar JJ; Baker S
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1163. PubMed ID: 21713025
[TBL] [Abstract][Full Text] [Related]
11. The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae.
Ambrose PG; Grasela DM
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):151-7. PubMed ID: 11109013
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistance in Salmonella Typhi.
Cooke FJ; Wain J; Threlfall EJ
BMJ; 2006 Aug; 333(7563):353-4. PubMed ID: 16902221
[No Abstract] [Full Text] [Related]
13. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
14. A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure.
Pham Thanh D; Karkey A; Dongol S; Ho Thi N; Thompson CN; Rabaa MA; Arjyal A; Holt KE; Wong V; Tran Vu Thieu N; Voong Vinh P; Ha Thanh T; Pradhan A; Shrestha SK; Gajurel D; Pickard D; Parry CM; Dougan G; Wolbers M; Dolecek C; Thwaites GE; Basnyat B; Baker S
Elife; 2016 Mar; 5():e14003. PubMed ID: 26974227
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
[TBL] [Abstract][Full Text] [Related]
16. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.
Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095
[TBL] [Abstract][Full Text] [Related]
17. The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.
Burgess DS; Frei CR; Lewis Ii JS; Fiebelkorn KR; Jorgensen JH
Clin Microbiol Infect; 2007 Jan; 13(1):33-9. PubMed ID: 17184285
[TBL] [Abstract][Full Text] [Related]
18. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.
Rupali P; Abraham OC; Jesudason MV; John TJ; Zachariah A; Sivaram S; Mathai D
Diagn Microbiol Infect Dis; 2004 May; 49(1):1-3. PubMed ID: 15135492
[TBL] [Abstract][Full Text] [Related]
19. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
20. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
